Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Blephagel
- Development stage
- Unknown
- Lead developer
- Théa Pharmaceuticals
- Modality
- Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
Blephagel is a hypoallergenic, preservative-free gel designed for the daily hygiene of sensitive eyelids and eyelashes. Developed by Laboratoires Théa, it is specifically formulated to mechanically remove mucus, crusts, and scales from the eyelid margins without irritating the eyes or damaging the outer layers of the epidermis. It is commonly used as an adjunctive treatment for blepharitis, dry eye syndrome associated with meibomian gland dysfunction, and for pre- and post-operative eyelid cleaning. The formulation utilizes Poloxamer 188 to emulsify and solubilize ocular secretions while maintaining skin hydration.
- Brand names
- Blephagel
Beyond the preview
Go deeper on Blephagel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Blephagel.